Kudos to the folks at Biotechnology Industry Organization (BIO) for selecting the industry’s “hot button” issues for panel discussions at the annual BIO Investor Forum (BIF) just concluded in San Francisco. In years past it has been my experience that…
SAN FRANCISCO ‑ I’m enough of a geek that I actually enjoy the details, devil and all, and so I love covering scientific conferences. At the same time, they can be daunting. So much scientific progress is incremental. A case…
SAN FRANCISCO ‑ At this week’s BIO Investor Forum in San Francisco, there was talk of how the biotech industry has squandered money, paying for infrastructure when it should have been paying only for development and continuing to fund programs…
Scientists at Beijing University of Chemical Technology have reported a way to express human-derived gelatin in yeast cells, and suggest that human-derived gelatin might be a useful alternative to pig-and cow derived gelatin for use in the food industry.
Editor’s note: This editorial about the Biotechnology Industry Organization conference, written by BioWorld’s publisher, originally appeared in a 2007 edition of BioWorld Perspectives, just before BIO in Boston. We asked him to update it for BIO 2011, which begins this…
Join the Conversation